MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02881nam a22005057a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231103135833.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211116s2014 enka|||| b||| 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780124081031 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
QCPL |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.99437 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Molecular diagnostics and treatment of pancreatic cancer |
| Remainder of title |
: systems and network biology approaches |
| Statement of responsibility, etc. |
/ edited by Asfar S. Azmi |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
London : |
| Name of producer, publisher, distributor, manufacturer |
Academic Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2014 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xx, 446 pages : |
| Other physical details |
illustrations |
| 336 ## - Content Type |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - Carrier Type |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section I. Current trends and advances in pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Epidemiology, treatment, and outcome of pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Advances in primary cell culture of pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Multimodal therapies for pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The role of Notch signaling pathway in the progression of pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section II. Gene expression profiling and bioinformatics analysis in pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Bioinformatics analysis of pancreas cancer genome in high-throughput genomic technologies |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Statistical analysis of high-dimensional data for pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Gene expression profiling in pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Genetic susceptibility and risk of pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section III. Pancreatic cancer proteomics |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Proteomics in pancreatic cancer translational research |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Proteomic differences and linkages between chemoresistance and metastasis of pancreatic cancer using knowledge-based pathway analysis |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
RNAi validation of pancreatic cancer antigens identified by cell surface proteomics |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section IV. Systems and network understanding of pancreatic cancer signaling |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The significance of the feedback loops between Kras and Ink4a in pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Systems biology of pancreatic cancer stem cells |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Characterizing the metabolomic effects of pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Prioritizing diagnostic, prognostic, and therapeutic microRNAs in pancreatic cancer : systems and network biology approaches |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section V. Systems approaches to pancreatic cancer therapeutics |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Integration of protein network activation mapping technology for personalized therapy : implications for pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Computational and biological evaluation of radioiodinated quinazolinone prodrug for targeting pancreatic cancer |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Systems and network pharmacology strategies for pancreatic Ductal adenocarcinoma therapy : a resources review |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pancreas |
| General subdivision |
Cancer |
| -- |
Molecular diagnosis |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Azmi, Asfar S. |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book |